Surfacide® Expands UV-C Disinfection in All MedStar Hospitals in Mid-Atlantic

Surfacide®, the leading company in UV-C disinfection technology, recently announced that it is expanding the use of its Helios® low-level UV-C Disinfection System to all ten hospitals in the MedStar Health system across the Mid-Atlantic region. With a renewed emphasis on operating room disinfection, the expansion enables MedStar Health to update some of its existing Surfacide® technology and deploy multiple new devices, making the Helios System more accessible to patients, staff, and visitors.

Since 2016, Surfacide® has collaborated strategically with MedStar Health to implement UV-C disinfection to reduce the environmental variable in infection prevention protocols. In addition, it is an integral part of CompassOne Healthcare’s ‘5 Pillars of Safety in Healthcare’ philosophy.

The Surfacide® Helios® system is the sole patented, low-level UV-C disinfection option that simultaneously employs three light-emitting ‘robots’ to reduce bacteria and viruses on contaminated surfaces significantly. It delivers UV-C energy to more exposed areas than individual devices, increasing power, dosage, and efficacy in a single cycle. The system is conveniently portable and configurable within various high-impact hospital areas, including patient rooms, ORs, patient bathrooms, burn units, labor & delivery, outpatient/ambulatory surgery, isolation wards, etc.

Founder and CEO of Surfacide®, Gunner Lyslo, shared, “With the expansion and renewed focus on a robust UV-C disinfection program, MedStar Health continues to demonstrate leadership and commitment to their patients, staff, and community.” He added, “We are thankful to work with such a tremendous partner and are confident that these strategies will positively impact patient and staff satisfaction.”